Managing Complications of Reconstructive and Aesthetic Breast Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine".

Deadline for manuscript submissions: 25 September 2024 | Viewed by 1199

Special Issue Editor


E-Mail Website
Guest Editor
Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Affiliated with the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Interests: aesthetic breast surgery; alloplastic breast reconstruction; autologous breast reconstruction; breast reduction; oncoplastic surgery; multidisciplinary breast team

Special Issue Information

Dear Colleagues,

It is our great pleasure to present this Special Issue on managing complications of reconstructive and aesthetic breast surgery. This topic is significant in breast surgery as timely diagnosis and treatment of breast surgery complications can dramatically change the course of recovery from surgery and have an imperative effect on the operative outcome. As our technique in breast surgery evolves, with the emergence of new devices and technologies, we have the opportunity to reduce the rate of complications and improve the management and outcome. We welcome authors to submit papers on managing complications in breast surgery, both aesthetic and reconstructive.

Prof. Dr. Yoav Barnea
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • complications
  • breast surgery 
  • aesthetic breast 
  • reconstructive breast 
  • complication management

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 2313 KiB  
Article
Our Experience in Diagnosing and Treating Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
by Gon Shoham, Oriana Haran, Roei Singolda, Ehab Madah, Ada Magen, Orit Golan, Tehillah Menes, Ehud Arad and Yoav Barnea
J. Clin. Med. 2024, 13(2), 366; https://doi.org/10.3390/jcm13020366 - 09 Jan 2024
Viewed by 1047
Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell lymphoma detected in association with textured implants. It presents as a fluid accumulation around the implant, usually years after the implantation. We present our experience in diagnosing and treating four patients with [...] Read more.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell lymphoma detected in association with textured implants. It presents as a fluid accumulation around the implant, usually years after the implantation. We present our experience in diagnosing and treating four patients with BIA-ALCL, each widely differing from the other. Data on patients’ surgical history, relevant medical information, and findings on pathological slides were retrieved from their medical charts and retrospectively reviewed. Each of the four patients was diagnosed with BIA-ALCL, one after breast augmentation, one after breast reconstruction with an implant, one after breast reconstruction with a latissimus dorsi flap and implant, and the fourth after the removal of breast implants. The cases were presented to a multidisciplinary team and subsequently underwent surgery. All four are currently free of tumors, as established by a negative follow-up via positron emission tomography-computed tomography. Although the incidence of BIA-ALCL is rare, these cases emphasize the need to rule out the diagnosis of BIA-ALCL in patients with textured implants or a history of implanted textured devices who present with symptoms such as late seroma or peri-implant mass. This pathology is typically indolent and slow-growing and heightened awareness for an early diagnosis could lead to quicker intervention and enhanced patient management. Full article
(This article belongs to the Special Issue Managing Complications of Reconstructive and Aesthetic Breast Surgery)
Show Figures

Figure 1

Back to TopTop